Literature DB >> 28947362

Making sense of genetic risk: A qualitative focus-group study of healthy participants in genomic research.

Jennifer Viberg Johansson1, Pär Segerdahl2, Ulrika Hösterey Ugander3, Mats G Hansson2, Sophie Langenskiöld4.   

Abstract

OBJECTIVE: It is well known that research participants want to receive genetic risk information that is about high risks, serious diseases and potential preventive measures. The aim of this study was to explore, by qualitative means, something less well known: how do healthy research participants themselves make sense of genetic risk information?
METHOD: A phenomenographic approach was chosen to explore research participants' understanding and assessment of genetic risk. We conducted four focus-group (N=16) interviews with participants in a research programme designed to identify biomarkers for cardiopulmonary disease.
RESULTS: Among the research participants, we found four ways of understanding genetic risk: as a binary concept, as an explanation, as revealing who I am (knowledge of oneself) and as affecting life ahead.
CONCLUSION: Research participants tend to understand genetic risk as a binary concept. This does not necessarily imply a misunderstanding of, or an irrational approach to, genetic risk. Rather, it may have a heuristic function in decision-making. PRACTICAL IMPLICATIONS: Risk communication may be enhanced by tailoring the communication to the participants' own lay conceptions. For example, researchers and counselors should address risk in binary terms, maybe looking out for how individual participants search for threshold figures.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conception of genetic risk; Genetic risk communication; Lay understanding; Making sense of genetic risk in research

Mesh:

Year:  2017        PMID: 28947362     DOI: 10.1016/j.pec.2017.09.009

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  4 in total

1.  Comprehension of skin cancer genetic risk feedback in primary care patients.

Authors:  Erva Khan; Kimberly A Kaphingst; Kirsten Meyer White; Andrew Sussman; Dolores Guest; Elizabeth Schofield; Yvonne T Dailey; Erika Robers; Matthew R Schwartz; Yuelin Li; David Buller; Keith Hunley; Marianne Berwick; Jennifer L Hay
Journal:  J Community Genet       Date:  2021-11-19

2.  Ethical concerns relating to genetic risk scores for suicide.

Authors:  Anna Docherty; Brent Kious; Teneille Brown; Leslie Francis; Louisa Stark; Brooks Keeshin; Jeffrey Botkin; Emily DiBlasi; Doug Gray; Hilary Coon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2021-09-01       Impact factor: 3.568

3.  The use of heuristics in genetic testing decision-making: A qualitative interview study.

Authors:  Bettina Maria Zimmermann; David Martin Shaw; Bernice Elger; Insa Koné
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.240

4.  Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words?

Authors:  Karen M Meagher; Kelsey Stuttgen Finn; Susan H Curtis; Jack Borucki; Annika T Beck; Amal W Cheema; Richard R Sharp
Journal:  Clin Transl Sci       Date:  2021-11-25       Impact factor: 4.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.